More than 300 members of the Canby Robinson Society and the Vanderbilt University Medical Center community joined Jeff Balser, MD, PhD, and his wife, Melinda, last week at Cheekwood Estate and Gardens for a reception celebrating the community of supporters who help VUMC in “redefining personalized care.”

On Sunday, May 6, Nashville played an important role in the nationwide launch of “All of Us,” the National Institutes of Health’s (NIH) research program that aims to collect the health information of 1 million or more research participants.

A new digital-first storytelling initiative, Defining Personalized Care, highlights the personal impact everyone at Vanderbilt Health makes with patients, families and each other.

A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.

The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6.

“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week.

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.